14 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
, dedication to human capital management is a core component of our corporate governance and culture. Our comprehensive approach to human capital management
8-K
EX-14.1
96nwgwycxo8pokg9hs
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
10-K
uj645ez w3tte
16 Mar 20
Annual report
11:09am
8-K
EX-99.1
7swmsv
4 Mar 20
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR TechnologyTM
8:52am
DEF 14A
uy5xmuqrpwk9ub3 2t
1 Oct 19
Definitive proxy
6:07am
8-K12B
f5y79 s3njd0dp998he0
14 Jun 19
Notification of registration of securities
5:10pm
424B3
0vk88q1d8qps
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
3fye2
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
blu v6xepk9
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next